On a November 2025 flight of Korea's Nuri rocket, a test module the size of a paperback rode to orbit with a thin-film solar cell bolted to its face. The cell was not the point of the launch. The data was.
Flexell Space, the Hanwha Systems spinout that built it, flew a second module on Nuri's fifth flight in October 2026. Two flights, two data sets, no commercial satellite yet. On October 28 the company signed with Singapore's Satoro for two more demonstrations, both on SpaceX Falcon 9, in 2027 and 2028.
That schedule is the signal. Space solar is crowded with laboratory efficiency records. Flight hours are scarce.
A flight record, not a lab record
Flexell develops cells from CIGS and perovskites, including tandem designs that stack a perovskite top layer over a CIGS bottom cell. Both chemistries promise more watts per kilogram than the gallium arsenide and silicon stacks that dominate satellite power today. Both also arrive with qualification baggage.
Perovskites are sensitive to moisture, heat and radiation. CIGS has flown before, but not at the cost and scale satellite constellations now demand. Flexell's pitch is low-cost, large-area, ultralight modules for constellations and space infrastructure, not one-off flagships.
The two Nuri modules were engineering tests. They produced ground-to-orbit comparisons, not a product catalog. Satoro gives the company a repeatable bus and a launch pathway outside Korea.
Why orbit is the only test that counts
Satoro turns a Korean test program into a two-flight validation series.
The 2028 data set, not the 2027 demo, is the one customers will underwrite.
Space solar cells face a stack of failure modes that a lab lamp cannot reproduce together: vacuum, thermal cycling across hundreds of degrees on a low-Earth-orbit satellite, atomic oxygen, micrometeoroid strikes, and trapped radiation. A cell that survives one cycle tells you little. A cell that survives thousands tells you whether the cover glass, interconnect and encapsulation hold.
Perovskite adds a chemistry problem. The material can degrade under ultraviolet light and ionizing radiation, and its performance can recover or drift after thermal excursions. Ground tests can isolate each effect. Orbit runs them at once.
That is why flight heritage functions as currency in this market. Satellite builders buy cells with a known degradation curve. A new entrant can promise a better curve; it cannot sell one without data.
The power budget problem
Every kilogram a satellite carries to orbit costs money, and solar arrays are a large share of a small satellite's mass and volume. A constellation multiplies that penalty by hundreds or thousands of units. Cheaper cells with higher specific power change the economics of the whole fleet, not only the power subsystem.
Gallium arsenide cells set the performance bar, with triple-junction designs setting the production efficiency benchmark and strong radiation tolerance. They are also expensive and supply-constrained. Silicon is cheaper and heavier. CIGS sits between the two on cost and mass, and it can be deposited on flexible substrates. Perovskite tandems promise another step up in specific power, if stability improves.
That condition is where Flexell's program lives. A datasheet can claim a strong tandem efficiency number. A satellite operator needs the number after five years in a radiation belt.
What Satoro actually sells
Satoro is a Singapore-based CubeSat manufacturer operating a Satellite-as-a-Service model. It has deployed 11 satellites across eight launches since 2021 and reports a 100% launch success rate. Under the agreement it builds the demonstration CubeSats, integrates the payload, coordinates the Falcon 9 launches and runs in-orbit operations.
Flexell supplies the cells and the test modules. The two companies will coordinate platform and payload requirements, then compare ground-test results with orbital performance over time.
The division matters. Flexell does not need to become a satellite integrator. Satoro does not need to become a solar-cell developer. Each side sells the part it already knows how to repeat.
CHRONICLE: Flexell Space flight record
────────────────────────────────
2021 · 🛰 Satoro begins deploying CubeSats
NOV 2025 · 🚀 First Flexell cell test on Nuri flight 4
OCT 2026 · 🚀 Second Nuri test; Satoro deal signed
2027 · 🧪 First Falcon 9 demonstration mission
2028 · 🧪 Second Falcon 9 demonstration mission
◉ NOW · 📊 Data review and customer qualification
Flight schedule compiled from Flexell Space, Satoro and SpaceNews statements, October-November 2026.
Two missions, one data series
One mission is an event. Two missions a year apart are a data series. The 2027 flight establishes a baseline: how the cells perform after launch, deployment and the first months of thermal cycling. The 2028 flight tests whether those numbers hold, drift or degrade in a way that changes the warranty.
Neither company disclosed contract value, satellite mass or orbit altitude. The public material also stops short of naming a commercial customer. Those gaps are normal at the demonstration stage. They also mean the announcements should be read as access to flight data, not as revenue.
Flexell's wider program fills in the context. Perovskite-Info reports the company leads a Korean national R&D project on space perovskite tandem modules and has worked with Airbus on perovskite/CIGS tandem PV for space. The Satoro deal sits on top of that work, not instead of it.
Satoro satellites deployed since 2021
Eight launches completed, with a reported 100% launch success rate. SpaceNews, 2026
Why Korea needs an export path
Korea has a domestic launch vehicle in Nuri and a space program that wants a commercial supply chain. Flexell's Nuri flights proved the cells could reach orbit on a Korean rocket. The Satoro agreement moves validation onto Falcon 9, a vehicle with broad commercial launch demand. That shift is as much about market access as engineering.
A Korean component supplier that can only fly on Nuri has a domestic story. One that flies on Falcon 9, with a Singapore integrator, can bid into European and Asian constellation programs. The two missions are small, but the signal is about eligibility.
What would count as success
Three results would move Flexell from test program to supplier. First, the cells must retain most of their beginning-of-life power after the first thermal cycles, with a degradation slope that customers can model. Second, the tandem stack must survive radiation doses that match the target orbit. Third, the module must survive launch vibration and deployment without microcracks that show up months later.
A single anomaly would not kill the program. A missing or ambiguous data set would. Satellite prime contractors qualify suppliers on documented history, and a gap in the record is harder to explain than a weak number.
The 2027 and 2028 flights give Flexell two chances to produce that record on a Western launch vehicle, with an Asian bus partner and a customer base that stretches from Korea to Europe. The company has not said which orbit, which customer or which chemistry flies first. Those details will decide how much the demonstrations are worth.
For now the bet is narrow and testable: buy flight hours, collect degradation data, and let the curve do the selling.